docetaxel anhydrous has been researched along with Nervous System Diseases in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Ayari, J; Balti, M; Ben Abdallah, I; Ben Hassen, M; Ben Nasr, S; Doghri, Y; Fendri, S; Haddaoui, A; Trigui, E; Zribi, A | 1 |
Mahdi, H; Maurer, K; Michener, C; Rose, PG | 1 |
Abe, H; Kawai, Y; Kubota, Y; Mori, T; Tani, T; Tomida, K; Umeda, T | 1 |
Aapro, MS; Ajani, J; Baker, J; Martin, M; Scotté, F; von Minckwitz, G; Winther, D | 1 |
Bangshöj, R; Boman, K; Graflund, M; Horvath, G; Lood, M; Malmström, H; Nygren, L; Sorbe, B; Swahn, M | 1 |
Bozionelou, V; Georgoulias, V; Kalykaki, A; Karachaliou, N; Kontopodis, E; Mavroudis, D; Papadimitraki, E; Syrigos, K; Tryfonidis, K; Ziras, N | 1 |
Chen, Y; Gui, Q; Huang, Y; Peng, P; Rao, J; Xi, Q; Xia, S; Yu, S; Zhuang, L; Zou, M | 1 |
Chen, YM; Chiu, CH; Lai, CL; Perng, RP; Su, WJ; Tsai, CM; Wang, GS | 1 |
Alakl, M; Clavel, M; Franklin, H; Piccart, M; Prove, AM; Steward, W; ten Bokkel Huinink, WW; Tursz, T; Verweij, J; Wanders, J | 1 |
Catimel, G; Clavel, M; Kerbrat, P; Kerger, J; Tursz, T; van Glabbeke, M; van Hoesel, QG; van Oosterom, AT; van Pottelsberghe, C; Verweij, J | 1 |
Apfel, SC | 1 |
Bove, L; Innocenti, P; Jandolo, B; Pace, A; Pietrangeli, A | 1 |
Hilkens, PH; Pronk, LC; van den Bent, MJ; van Putten, WL; Vecht, CJ; Verweij, J | 1 |
Aapro, MS | 1 |
Booser, DJ; Burris, HA; Earhart, RH; Erban, JK; Esparza-Guerra, L; Holmes, FA; Hortobagyi, GN; Jones, SE; Mennel, RG; Rahman, Z; Ravdin, PM; Schottstaedt, MW; Valero, V; Von Hoff, DD | 1 |
Hilkens, PH; Pronk, LC; Stoter, G; van den Bent, MJ; van Putten, WL; Verweij, J | 1 |
Beer, TM; Bubalo, JS | 1 |
Beuzeboc, P; Diéras, V; Laurence, V; Pierga, JY; Pouillart, P | 1 |
Depisch, D; Haider, K; Kornek, GV; Kovats, E; Kwasny, W; Lang, F; Payrits, T; Raderer, M; Scheithauer, W; Schüll, B | 1 |
4 review(s) available for docetaxel anhydrous and Nervous System Diseases
Article | Year |
---|---|
Docetaxel-related side effects and their management.
Topics: Antineoplastic Agents; Asthenia; Docetaxel; Drug Administration Schedule; Drug Hypersensitivity; Drug Monitoring; Edema; Evidence-Based Practice; Humans; Nail Diseases; Neoplasms; Nervous System Diseases; Neutropenia; Nursing Assessment; Oncology Nursing; Patient Selection; Practice Guidelines as Topic; Quality of Life; Severity of Illness Index; Taxoids | 2009 |
Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Synergism; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Neoplasm Metastasis; Nervous System Diseases; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Vinblastine; Vinorelbine | 1997 |
Complications of chemotherapy for prostate cancer.
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Docetaxel; Gastrointestinal Diseases; Humans; Male; Mitoxantrone; Nervous System Diseases; Paclitaxel; Prednisone; Prostatic Neoplasms; Taxoids | 2001 |
Interaction between Herceptin and taxanes.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Heart Diseases; Humans; Mice; Mice, Nude; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Nervous System Diseases; Neutropenia; Paclitaxel; Palliative Care; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptor, ErbB-3; Salvage Therapy; Survival Analysis; Taxoids; Trastuzumab; Treatment Outcome; Xenograft Model Antitumor Assays | 2001 |
10 trial(s) available for docetaxel anhydrous and Nervous System Diseases
Article | Year |
---|---|
The Kampo medicine Goshajinkigan prevents neuropathy in breast cancer patients treated with docetaxel.
Topics: Adult; Aged; Breast Neoplasms; Docetaxel; Drugs, Chinese Herbal; Female; Humans; Medicine, Kampo; Middle Aged; Nervous System Diseases; Taxoids; Vitamin B 12 | 2013 |
A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: neurological toxicity and quality-of-life evaluation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies; Quality of Life; Survival Rate; Taxoids | 2012 |
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Remission Induction; Salvage Therapy; Taxoids; Treatment Outcome | 2012 |
Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Endpoint Determination; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Nervous System Diseases; Quality of Life; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome; Vomiting, Anticipatory | 2005 |
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Europe; Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Remission Induction; Taxoids | 1994 |
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Europe; Female; Humans; Leukopenia; Male; Middle Aged; Nervous System Diseases; Paclitaxel; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Taxoids; Thrombocytopenia | 1994 |
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Nervous System Diseases; Paclitaxel; Paresthesia; Taxoids | 1997 |
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Edema; Female; Fever; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Taxoids | 1998 |
Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Docetaxel; Female; Glucocorticoids; Humans; Male; Middle Aged; Neoplasms; Nervous System Diseases; Paclitaxel; Prospective Studies; Taxoids | 1998 |
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Docetaxel; Fatigue; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Nausea; Nervous System Diseases; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome | 2002 |
5 other study(ies) available for docetaxel anhydrous and Nervous System Diseases
Article | Year |
---|---|
Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Digestive System Diseases; Docetaxel; Fatigue; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Nail Diseases; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tunisia | 2021 |
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
Topics: Adult; Aged; Albumins; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Retreatment; Retrospective Studies; Taxoids; Thrombocytopenia | 2017 |
Pregabalin attenuates docetaxel-induced neuropathy in rats.
Topics: Animals; Docetaxel; gamma-Aminobutyric Acid; Ganglia, Spinal; Male; Nervous System Diseases; Pregabalin; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Taxoids | 2012 |
Docetaxel neuropathy.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Nervous System Diseases; Paclitaxel; Taxoids | 1996 |
Docetaxel neuropathy.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Nervous System Diseases; Paclitaxel; Taxoids | 1996 |